SCHEMBL7666283

SCHEMBL7666283

CCOc1ccc(Nc2nc(Cl)c3[nH]cnc3n2)cn1

nearest known ligand 0.60

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
POLA1 P09884 5/20 0.60
CDK2 P24941 4/20 0.49
LRRK2 Q5S007 1/20 0.46
PIK3CA P42336 5/20 0.45
NEK2 P51955 1/20 0.43
MTOR P42345 2/20 0.43
SYK P43405 1/20 0.42
CCNT1 O60563 1/20 0.41
CDK1 P06493 1/20 0.41
CCNB1 P14635 1/20 0.41
CDK7 P50613 1/20 0.41
CDK9 P50750 1/20 0.41
CCNH P51946 1/20 0.41
PIK3CD O00329 1/20 0.41
PIK3CB P42338 1/20 0.41
PIK3CG P48736 1/20 0.41
KDM4E B2RXH2 1/20 0.40
NFKB1 P19838 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20363223 0.82 KDM4E (0.41) POLA1CDK2PIK3CAMTORCDK1
SCHEMBL21544599 0.76 POLB (0.49) PIK3CAMTORSYKKDM4ENFKB1
SCHEMBL5779077 0.74 POLA1 (0.60) POLA1CDK2NEK2SYK
SCHEMBL8539783 0.74 CDK2 (0.64) POLA1CDK2NEK2CCNT1CDK1
SCHEMBL7672313 0.72 POLA1 (0.38) POLA1CDK2PIK3CAMTORKDM4E
SCHEMBL7672177 0.68 CCNE1 (0.44) CDK2KDM4ENFKB1
SCHEMBL27824249 0.66 DPP4 (0.61) POLA1CDK2
SCHEMBL20363222 0.66 MEN1 (0.35) POLA1PIK3CAMTORKDM4ENFKB1
SCHEMBL9278629 0.66 POLA1 (0.59) POLA1CDK2CDK1CCNB1
Alcohol SCHEMBL27897029 0.65 DPP4 (0.54) POLA1CDK2CDK1CCNB1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6414147-B1 DIAGNOSIS AND TREATMENT OF ANXIETY, DEPRESSION, SLEEP AND SEIZURE DISORDERS, DOWN'S SYNDROME, OVERDOSE WITH BENZODIAZEPINE DRUGS, AND FOR ENHANCEMENT OF MEMORY NEUROGEN CORPORATION 2002-07-02 US disclosed